IL-6 and matrix metalloproteinase-1 are regulated by the cyclin-dependent kinase inhibitor p21 in synovial fibroblasts

Journal of Immunology

Volumn 170, Issue 2, 2003, Pages 838-845

  Perlman, Harris ^a   Bradley, Kathleen ^a   Liu, Hongtao ^a   Cole, Shawn ^a   Shamiyeh, Eli ^a   Smith, Roy C ^a   Walsh, Kenneth ^a   Fiore, Stefano ^a   Koch, Alisa E ^a   Firestein, Gary S ^a   Haines III, G Kenneth ^a   Pope, Richard M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; CYTOKINE; INTERLEUKIN 6; INTERSTITIAL COLLAGENASE; PROTEIN P21; STROMELYSIN; TRANSCRIPTION FACTOR AP 1;

ADENOVIRUS; ADENOVIRUS P21; ARTICLE; AUTOIMMUNE DISEASE; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DOWN REGULATION; FIBROBLAST; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; JOINT DESTRUCTION; OSTEOARTHRITIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; RHEUMATOID ARTHRITIS; SYNOVIUM; VIRAL GENE DELIVERY SYSTEM;

EID: 0037438376     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.2.838     Document Type: Article

References (66)

1. Firestein, G. S. 1996. Invasive fibroblast-like synoviocytes in rheumatoid arthritis. Arthritis Rheum. 39:1781.
2. Hashimoto, S., R. L. Ochs, S. Komiya, and M. Lotz. 1998. Linkage of chondrocyte apoptosis and cartilage degradation in human osteoarthritis. Arthritis Rheum. 41:1632.
3. Tak, P. P., D. M. Gerlag, K. R. Aupperle, D. A. van de Geest, M. Overbeek, B. L. Bennett, D. L. Boyle, A. M. Manning, and G. S. Firestein. 2001. Inhibitor of nuclear factor κB kinase β is a key regulator of synovial inflammation. Arthritis Rheum. 44:1897.
4. Smith, C., E. Andreakos, J. B. Crawley, F. M. Brcnnan, M. Feldmann, and B. M. Foxwell. 2001. NF-κB-inducing kinase is dispensable for activation of NF-κB in inflammatory settings but essential for lymphotoxin β receptor activation of NF-κB in primary human fibroblasts. J. Immunol. 167:5895.
5. Han, Z., D. L. Boyle, L. Chang, B. Bennett, M. Karin, L. Yang, A. M. Manning, and G. S. Firestein. 2001. c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. J. Clin. Invest. 108:73.
6. Georganas, C., H. Liu, H. Perlman, A. Hoffmann, B. Thimmapaya, and R. M. Pope. 2000. Regulation of IL-6 and IL-8 expression in rheumatoid arthritis synovial fibroblasts: the dominant role for NF-κB but not C/EBPβ or c-Jun. J. Immunol. 165:7199.
7. Aupperle, K., B. Bennett, Z. Han, D. Boyle, A. Manning, and G. Firestein. 2001, NF-κB regulation by IκB kinase-2 in rheumatoid arthritis synoviocytes. J. Immunol. 166:2705.
8. Alvaro-Gracia, J. M., N. J. Zvaifler, and G. S. Firestein, 1990. Cytokines in chronic inflammatory arthritis. V. Mutual antagonism between interferon-gamma and tumor necrosis factor-α on HLA-DR expression, proliferation, collagenase production, and granulocyte macrophage colony-stimulating factor production by rheumatoid arthritis synoviocytes. J. Clin. Invest. 86:1790.
9. Dechanet, J., J. Briolay, M. C. Rissoan, P. Chomarat, J. P. Galizzi, J. Banchereau, and P. Miossec. 1993. IL-4 inhibits growth factor-stimulated rheumatoid synoviocyte proliferation by blocking the early phases of the cell cycle. J. Immunol. 151:4908.
10. Harbour, J. W., and D. C. Dean. 2000. Rb function in cell-cycle regulation and apoptosis, Nat. Cell. Biol. 2:E65.
11. Harbour, J. W., and D. C. Dean. 2000. The Rb/E2F pathway: expanding roles and emerging paradigms. Genes Dev. 14:2393.
12. Helin, K. 1998. Regulation of cell proliferation by the E2F transcription factors, Curr. Opin. Genet. Dev 8:28.
13. Gao, C. Y., and P. S. Zelenka. 1997. Cyclins, cyclin-dependent kinases and differentiation. BioEssays 19:307.
14. Sherr, C. J. 1996. Cancer cell cycles, Science 274:1672.
15. Taniguchi, K., H. Kohsaka, N. Inoue, Y. Terada, H. Ito, K. Hirokawa, and N. Miyasaka. 1999. Induction of the p16INK4a senescence gene as a new therapeutic strategy for the treatment of rheumatoid arthritis. Nat. Med. 5:760,
16. Nonomura, Y., H. Kohsaka, K. Nasu, Y. Terada, M. Ikeda, and N. Miyasaka. 2001. Suppression of arthritis by forced expression of cyclin-dependent kinase inhibitor p21(Cip1) gene into the joints. Int. ImmunoL 13:723.
17. Nasu, K., H. Kohsaka, Y. Nonomura, Y. Terada, H. Ito, K. Hirokawa, and N. Miyasaka. 2000. Adenoviral transfer of cyclin-dependent kinase inhibitor genes suppresses collagen-induced arthritis in mice. J. Immunol. 165:7246.
18. Perlman, H., H, Liu, C. Georganas, J. M. Woods, M. A. Amin, A. E. Koch, T. Wickham, I. Kovesdi, T. Mano, K. Walsh, et al. 2002. Modifications in adenoviral coat fiber proteins and transcriptional regulatory sequences enhance transgene expression. J. Rheum. 29:1593.
19. Arnett, F. C., S. M. Edworthy, D. A. Bloch, D. J. McShane, J. F. Fries, N. S. Cooper, L. A. Healy, S. R. Kaplan, M. H. Liang, H. S. Luthra, et al. 1988. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31:315.
20. Altman, R., G. Alarcon, D. Appelrouth, D. Bloch, D. Borenstein, K. Brandt, C. Brown, T. D. Cooke, W. Daniel, D. Feldman, et al. 1991, The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum. 34:505.
21. Perlman, H., L. J. Pagliari, C. Georganas, T. Mano, K. Walsh, and R. M. Pope. 1999. Flice inhibitory protein expression during macrophage differentiation confers resistance to Fas-mediated apoptosis. J. Exp. Med. 190:1679.
22. Perlman, H., C. Georganas, L. J. Pagliari, A. E. Koch, K. Haines, and R. M. Pope. 2000. Bcl-2 expression in svnovial fibroblasts is essential for maintaining mitochondrial homeostasis and cell viability. J. Immunol. 164:5227.
23. Halloran, M. M., Z. Szekanecz, N. Barquin, G. K. Haines, and A. E. Koch. 1996. Cellular adhesion molecules in rat adjuvant arthritis. Arthritis Rheum. 39:810.
24. Szekanecz, Z., M. M. Halloran, M. V. Volin, J. M. Woods, R. M. Strieter, G. Kenneth Haines III, S. L. Kunkel, M, D. Burdick, and A. E. Koch, 2000. Temporal expression of inflammatory cytokines and chemokines in rat adjuvant-induced arthritis. Arthritis Rheum. 43:1266.
25. Sodin-Semrl, S., B. Taddeo, D. Tseng, J. Varga, and S. Fiore. 2000. Lipoxin A4 inhibits IL-1β-induced IL-6, IL-8, and matrix metalloproteinase-3 production in human synovial fibroblasts and enhances synthesis of tissue inhibitors of metalloproteinases. J. Immunol. 164:2660.
26. Koch, A. E., S. L. Kunkel, L. A. Harlow, B. Johnson, H. L. Evanoff, G. K. Haines, M. D. Burdick, R. M. Pope, and R. M. Strieter. 1992. Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis. J. Clin. Invest. 90:772.
27. Koch, A. E., S, L. Kunkel, L. A. Harlow, D. D. Mazarakis, G. K. Haines, M. D. Burdick, R. M. Pope, A. Walz, and R. M. Strieter. 1994. Epithelial neutrophil activating peptide-78: a novel chemotactic cytokine for neutrophils in arthritis. J. Clin. Invest. 94:1012.
28. Han, Z., D. L. Boyle, K. R. Aupperle, B. Bennett, A. M. Manning, and G. S. Firestein. 1999. Jun N-terminal kinase in rheumatoid arthritis. J. Pharmacol. Exp. Ther. 291:124.
29. Johnson, B. A., G. K. Haines, L. A. Harlow, and A. E. Koch. 1993. Adhesion molecule expression in human synovial tissue. Arthritis Rheum. 36:137.
30. CIP1-mediated inhibition of cell proliferation by overexpression of the gax homeodomain gene. Genes Dev. 11:1674.
31. CiP1 expression and G1 cell cycle arrest. J. Biol. Chem. 273:13713.
32. Perlman, H., M. Sata, A. Le Roux, T. Sedlak. D. Branellec, and K. Walsh. 1998. Bax-mediated cell death by the Gax homeoprotein requires mitogen-activation but is independent of cell cycle activity. EMBO J. 17:3576.
33. Smith, R. C., K. N, Wills, D. Antelman, H. Perlman, L. N. Truong, K. Krasinski, and K. Walsh. 1997. Adenoviral constructs encoding phosphorylation-competent full-length and truncated forms of the human retinoblastoma protein inhibit myocyte proliferation and neointima formation. Circulation 96:1899.
34. Perlman, H., M. Sata, K. Krasinski, T. Dorai, R. Buttyan, and R. Walsh. 2000. Adenovirus-encoded hammerhead ribozyme to Bcl-2 inhibits neointimal hyperplasia and induces vascular smooth muscle cell apoptosis. Cardiovasc. Res. 45: 570.
35. Zagariya, A., S. Mungre, R. Lovis, M. Birrer, S. Ness, B. Thimmapaya, and R. Pope. 1998. Tumor necrosis α gene regulation: enhancement of C/EBPβ-induced activation by c-Jun. Mol. Cell. Biol. 18:2815.
36. Fee, D., D. Grzybicki, M. Dobbs, S. Ihyer, J. Clotfelter, S. Macvilay, M. N. Hart, M. Sandor, and Z. Fabry. 2000. Interleukin 6 promotes vasculogenesis of murine brain microvessel endothelial cells. Cytokine 12:655.
37. Van Meurs, J. B., P. L. Van Lent, L. A. Joosten, P. M. Van der Kraan, and W. B. Van den Berg. 1997. Quantification of mRNA levels in joint capsule and articular cartilage of the murine knee joint by RT-PCR: kinetics of stromelysin and IL-1 mRNA levels during arthritis. Rheumatol. Int. 16:197.
38. Pagliari, L. J., H. Perlman, H. Liu, and R. M. Pope. 2000. Macrophages require constitutive NF-κB activation To maintain A1 expression and mitochondrial homeostasis. Mol. Cell. Biol. 20:8855.
39. Aupperle, K. R., B. L. Bennett, D. L. Boyle, P. P. Tak, A. M. Manning, and G. S. Firestein. 1999, NF-κB regulation by IκB kinase in primary fibroblast-like synoviocytes. J. Immunol. 163:427.
40. Barchowsky, A., D. Frieta, and M. P. Vincenti. 2000. Integration of the NF-κB and mitogen-activated protein kinase/AP-1 pathways at the cellagenase-1 promoter: divergence of IL-1 and TNF-dependent signal transduction in rabbit primary synovial fibroblasts. Cytokine 12:1469.
41. Ozanne, B. W., L. McGarry, H. J. Spence, I. Johnston, J. Winnie, L. Meagher, and G. Stapleton. 2000. Transcriptional regulation of cell invasion: AP-1 regulation of a multigenic invasion programme. Eur. J. Cancer. 36:1640.
42. Shiozawa, S., K. Shimizu, K. Tanaka, and K. Hino. 1997. Studies on the contribution of c-fos/AP-1 to arthritic joint destruction. J. Clin. Invest. 99:1210.
43. Wakisaka, S., N. Suzuki, N. Saito, T. Ochi, and T. Sakane. 1998. Possible correction of abnormal rheumatoid arthritis synovial cell function by jun D transfection in vitro. Arthritis Rheum. 41:470.
44. El-Deiry, W. S., T, Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817.
45. Vousden, K. H., and G. F. Woude. 2000. The ins and outs of p53. Nat. Cell. Biol. 2:E178.
46. Vousden, K. H. 2000. p53: death star. Cell 103:691.
47. Firestein, G. S., K. Nguyen, K. R. Aupperle, M. Yeo, D. L. Boyle, and N. J. Zvaifler. 1996. Apoptosis in rheumatoid arthritis: p53 overexpression in rheumatoid arthritis synovium. Am. J. Pathol. 149:2143.
48. Tak, P. P., T. J. Smeets, D. L. Boyle, M. C. Kraan, Y. Shi, S. Zhuang, N. J. Zvaifier, F. C. Breedveld, and G. S. Firestein. 1999. p53 overexpression in synovial tissue from patients with early and longstanding rheumatoid arthritis compared with patients with reactive arthritis and osteoarthritis. Arthritis Rheum. 42:948.
49. Inazuka, M., T. Tahira, T. Horiuchi, S. Harashima, T. Sawabe, M. Kondo, H. Miyahara, and K. Hayashi. 2000. Analysis of p53 tumour suppressor gene somatic mutations in rheumatoid arthritis synovium. Rheumatology 39:262.
50. Reme, T., A. Travaglio, E. Gueydon, L. Adla, C. Jorgensen, and J. Sany. 1998, Mutations of the p53 tumour suppressor gene in erosive rheumatoid synovial tissue. Clin. Exp. Immunol. 111:353.
51. , Firestein, G. S., F. Echeverri, M. Yeo, N. J. Zvaifler, and D. R. Green. 1997. Somatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium. Proc. Natl. Acad. Sci. USA 94:10895.
52. Kulimann, F., M. Judex, I. Neudecker, S. Lechner, H. P. Justen, D. R. Green, D. Wessinghage, G. S. Firestein, S. Gay, J. Scholmerich, et al. 1999. Analysis of the p53 tumor suppressor gene in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum. 42:1594.
53. Han, Z., D. L. Boyle, B. Y. Shi, D. R. Green, and G. S. Firestein. 1999. Dominant-negative p53 mutations in rheumatoid arthritis. Arthritis Rheum. 42:1088.
54. Santhanam, U., A. Ray, and P. B. Sehgal. 1991. Repression of the interleukin 6 gene promoter by p53 and the retinoblastoma susceptibility gene product. Proc. Natl. Acad. Sci. USA 88:7605.
55. Sun, Y., L. Wenger, J. L. Rutter, C. E. Brinckerhoff, and H. S. Cheung. 1999. Human metalloproteinase-1 (collagenase-1) is a tumor suppressor protein p53 target gene. Ann. NY Acad. Sci. 878:638.
56. Sun, Y., L. Wenger, J. L. Rutter, C. E. Brinckerhoff, and H. S. Cheung. 1999. p53 down-regulates human matrix metalloproteinase-1 (collagenase-1) gene expression. J. Biol. Chem. 274:11535.
57. Yamanishi, Y., D. L. Boyle, M. J. Pinkoski, A. Mahboubi, T. Lin, Z. Han, N. J. Zvaifler, D. R. Green, and G. S. Firestein. 2002. Regulation of joint destruction and inflammation by p53 in collagen-induced arthritis. Am. J. Pathol. 160:123.
58. Sun, Y., J. M. Cheung, J. Martel-Pelletier, J. P. Pelletier, L. Wenger, R. D. Altman, D. S. Howell, and H. S. Cheung. 2000. Wild type and mutant p53 differentially regulate the gene expression of human collagenase-3 (hMMP-13). J. Biol. Chem. 275:11327.
59. Chang, L., and M. Karin. 2001. Mammalian MAP kinase signalling cascades. Nature 410:37.
60. Davis, R. J. 2000. Signal transduction by the JNK group of MAP kinases. Cell 103:239.
61. Shim, J., H. Lee, J. Park, H. Kim, and E. J. Choi. 1996. A non-enzymatic p21 protein inhibitor of stress-activated protein kinases. Nature 381: 804.
62. Roivainen, A., K. O. Soderstrom, L. Pirila, H. Aro, P. Kortekangas, R. Merilahti-Palo, T. Yli-Jama, A. Toivanen, and P. Toivanen. 1996. Oncoprotein expression in human synovial tissue: an immunohistochemical study of different types of arthritis. Br. J. Rheumatol. 35:933.
63. Asahara, H., K. Fujisawa, T. Kobata, T. Hasunuma, T. Maeda, M. Asanuma, N. Ogawa, H. Inoue, T. Sumida, and K. Nishioka. 1997. Direct evidence of high DNA binding activity of transcription factor AP-1 in rheumatoid arthritis synovium. Arthritis Rheum. 40:912.
64. Han, Z., D. L. Boyle, A. M. Manning, and G. S. Firestein. 1998. AP-1 and NF-κB regulation in rheumatoid arthritis and murine collagen-induced arthritis. Autoimmunity 28:197.
65. Salvador, J. M., M. C. Hollander, A. T. Nguyen, J. B. Kopp, L. Barisoni, J. K. Moore, J. D. Ashwell, and A. J. Fornace, Jr. 2002. Mice lacking the p53-effector gene Gadd45a develop a lupus-like syndrome. Immunity 16:499.
66. Balomenos, D., J. Martin-Caballero, M. I. Garcia, I. Prieto, J. M. Flores, M. Serrano, and A. C. Martinez. 2000. The cell cycle inhibitor p21 controls T-cell proliferation and sex-linked lupus development. Nat. Med. 6:171.